James M Daly
CIK 1560782 · EVP, Chief Commercial Officer · last filed 2026-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.61M
Companies
7
Total Filings
81
Lifetime Open-Market Net
-$41.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYTK | Director | 3,390 | $76.76 | $260.2K | $0 | 5 | 2026-07-16 |
| MDGL | Director | 3,081 | $510.04 | $1.57M | -$13.59M | 10 | 2026-06-18 |
| ACAD | Director | 12,148 | $29.21 | $354.8K | -$3.15M | 16 | 2026-06-01 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Director | 20,503 | — | — | -$2.29M | 11 | 2023-08-15 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Director | 109,873 | $0.07 | $8.2K | $0 | 13 | 2023-01-05 |
| CHIMERIX INC (CMRX) Delisted | Director | — | $8.54 | — | $0 | 5 | 2019-06-24 |
| INCY | EVP, Chief Commercial Officer | 3,521 | $120.56 | $424.5K | -$22.72M | 16 | 2015-06-25 |
Recent Filings · Page 8 of 9
81 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-09 | INCY | Grant (A) | +3,022 | $0 | EDGAR |
| 2014-12-29 | INCY | Mixed | — | -$637.7K | EDGAR |
| 2014-11-26 | INCY | Mixed | — | -$633.7K | EDGAR |
| 2014-10-24 | INCY | Mixed | — | -$404.9K | EDGAR |
| 2014-09-25 | INCY | Mixed | — | -$340.1K | EDGAR |
| 2014-08-27 | INCY | Mixed | — | -$387.9K | EDGAR |
| 2014-07-25 | INCY | Mixed | — | -$349.9K | EDGAR |
| 2014-02-18 | INCY | Mixed | — | -$7.84M | EDGAR |
| 2014-01-23 | INCY | Grant (A) | — | $0 | EDGAR |
| 2013-02-12 | INCY | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.